Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Wholesome Cinco De Mayo recipes
Posted: May 5, 2021 / 3:05 PM MDT /. Updated: May 5, 2021 / 3:06 PM MDT
Lifestyle expert Jennifer Sloan says you don't have...
Important Oils Market 2020 Improvement Traits & Aggressive Evaluation by Main Trade Gamers 2026...
A new market research report from Facts and Factors Market Research (fnfresearch.com), on "Market overview of essential oils by trends, top manufacturers in the...